We Serve All Stakeholders of Clinical Research

At Jeeva, we are passionate about making clinical research faster, more accessible, diverse, and least burdensome for researchers and patients. Validated, high-quality, compliant software systems are needed for remote patient education, enrollment, evidence generation, and retention in a variety of research programs involving human subjects. These include:

  • Biopharmaceutical sponsors for their phase 0, 1, 2, 3, or 4 clinical trials
  • A white-labeled solution for Contract Research Organizations (CROs) as partners
  • Patient advocacy groups for their patient registry or natural history studies
  • Academic researchers for their investigator-initiated trials and longitudinal cohort studies, and
  • Public health research programs involving population-scale surveillance, safe quarantine, or safety studies
We Serve All Stakeholders - Who We Serve
Patients & Study Volunteers Box Image - Who We Serve
Patients & Study Volunteers
Research Investigators Box Image - Who We Serve
Research Investigators
Sponsors Box Image - Who We Serve
Sponsors
CROs Box Image - Who We Serve
CROs

A Platform that Addresses ClinOps Stakeholder’s Concerns

Who We Serve

Jeeva empowers study teams to:

Jeeva ePowers Study

All while boosting engagement between researchers and patients by email, SMS, audio calling, and video calling with a single login for a study from any browser-enabled mobile device.

  • Remotely screen, recruit and retain more participants faster
  • Elevate electronic patient-reported outcomes (ePRO) to a whole new level during a live video call (vPRO).
  • Directly capture electronic study data, lab reports, safety, medical history, and clinical outcomes assessments (eCOA) using the drag-and-drop form builder including during a live video call between investigator and patient.
  • Minimize investigator burden by capturing patient self-reported information at a time and place convenient for the patient.
  • Maximize patient satisfaction, by providing flexibility for them to complete study participation and follow-up visits remotely or in person.
  • Reduce operational costs by minimizing the need for in-person monitoring visits as all study staff will have real-time access to the central clinical database.
Rare Disease Registries - Who We Serve

Rare Disease Registries or Natural History Studies

Longitudinal cohort studies collect clinical, behavioral, lifestyle, and environmental data from participants in real-world settings over extended periods of time. Our bring-your-own-device platform makes it easy for study investigators to onboard, engage, and retain participants. The FDA and NIH's National Center for Advanced Translational Sciences have encouraged patient groups to drive establishment of high-quality institutional review board-approved patient registries and natural history studies.

Chronic Diseases Clinical Studies - Who We Serve

Chronic Diseases Clinical Studies

Patients suffering from chronic conditions such as Diabetes, Cardiovascular, or neurobehavioral disorders lack the high motivation to take on the significant burden of participating in a clinical trial. By utilizing a protocol design that minimizes patient burden by enabling the flexibility of remote enrollment, participation, and long-term engagement, you can maximize the probability of trial success. With a single integrated and modular software subscription service that can be flexibly configured to support complex study designs, you can win more global clinical trial opportunities with sponsors.

Investigator Initiated Trials - Who We Serve

Investigator Initiated Trials

Our experienced coordinators provide the highest quality of video conferencing visits for patients and caregivers. Our goal is to help simplify and manage the trial operations to minimize burden, reduce dropouts, improve compliance, and accelerate the development of therapies. Investigator initiated single site studies suffer from lack of funding necessary to conduct certain large-scale, real-world evidence, observational, or drug repurposing studies of medicines already proven safe. Jeeva eClinical cloud platform offers a cost-effective solution to quickly setup and conduct clinical studies of any scale or duration, with or without patient travel involved.

Long-Term Follow Up Studies - Who We Serve

Long-Term Follow Up Studies

Gene therapy trials typically involve one-time therapy administration with long-term follow-up with patients for safety monitoring. Physical site visit requirements over a long period of time, place an undue burden on trial participants. Jeeva simplifies this process by fitting the trial into the lifestyle of patients. Cell and gene therapies are the most advanced form of one-and-done treatments for patients with rare genetic diseases including cancer. FDA guidelines in January 2020 require sponsors of such therapy trials to monitor patients over extended periods of time to better understand the durability of these treatments. Most of the existing clinical trial management or electronic data capture tools were designed for traditional brick and Read More

Request Demo

Compliance & Quality Programs Supported

HIPAA
GCP
FDA
Eu General Data Protection Regulation
AICPA

Get Live Demonstration of Jeeva eClinical Cloud on Your Study Protocol

We interviewed a couple of thousand stakeholders of medical research including patients, researchers, sponsors, CROs, regulators, and key opinion leaders. They all expressed dissatisfaction and complained about the poor experience with conducting or participating in clinical trials, lack of flexibility, or having made wrong choices early on in trial design resulting in protocol amendments or patient reconsenting, logistical burdens of patient recruitment, and retention. Our collective response is the Jeeva eClinical Cloud software as a service (SaaS) platform that addresses all stakeholder concerns and provides a flexible user experience on any browser-enabled mobile device. Accelerating timelines, minimizing cost, enabling collaborations among all stakeholders on a single platform, and bi-directional communications between study users and patients by email, SMS, audio, and video calling.

Discuss Your Study Requirements
Live Demonstration of Jeeva eClinical

Client Testimonials

Read all Testimonials

Client Testimonials

Jeeva is a game-changer for our rare diseases site/CRO. It is unfair to expect patients or healthy volunteers to visit a hospital or clinic when it is not necessary when a task can be effectively completed safely, remotely, and from the comfort of where they live.
Marshall Summar, MD, PhD, Director, Rare Disease Institute, Children's National Hospital
Marshall Summar, MD, Ph.DCEO, Uncommon Cures LLC
Jeeva platform & service is aligned with our vision to making CAR-T cell therapies affordable in emerging markets.
Rahul Purwar, Ph.D.
Rahul Purwar, Ph.D. Founder at ImmunoACT
Jeeva's simple and elegant video consenting solution saves me hundreds of hours of repetitive process of obtaining informed consent from study participants
Kimberly Chapman, MD, Ph.D.
Kimberly Chapman, MD, Ph.D.Principal Investigator, Childrens National Medical Center
Jeeva is backed by excellent customer service. We are enjoying our seamless transition to this platform for our longitudinal cohort study. Flexibility in programming.
Prof Lawrence Cheskin GMU
Lawrence Cheskin, MDProfessor and Chair, Nutrition and Food Studies, George Mason University
We are pleased to collaborate with Jeeva for the eCOA module for our investigator initiated observational study to understand toileting use by individuals with certain brain disorders
Dr. Terry Jo Bichell
Dr. Terry Jo BichellCombinedBrain
Very happy with the easy-to-use interface and the detailed user manual, which are supported by a highly responsive team! Jeeva's technology platform enables our patient concierge.
Nisha Venugopal, Ph.D.
Nisha Venugopal, Ph.D.Program Manager, IndoUS Organization for Rare Diseases
In looking for a software partner, our research coordinators and investigators in the field could call the Jeeva team anytime, get reliable support, and have reassurance as we enroll patients on the go. You can count on Jeeva when time is of the essence in operationalizing a clinical trial.
Dr. Emmanuel Gorospe
Dr. Emmanuel GorospeChief Medical Officer of Great Lakes Research Institute
There is an urgent need for validated tools to help ensure the continuity and integrity of clinical trial operations during and beyond the pandemic.
Frank Sasinowski, MPH, JD, Legendary Leader in Rare Diseases and Orphan Drugs Regulations
Frank Sasinowski, MPH, JDA legendary leader in Rare Diseases & Orphan Drugs Regulations
We are pleased to provide financial support - both in the form of a grant and an equity investment - to Jeeva. Jeeva is an excellent example of the kind of startup we look to support and pursuing an enormous market opportunity. We wish Dr. Rajasimha and his team the best of luck as they continue to build this company.
Sean Mallon
Sean MallonVice President, Virginia Innovation Partnership Corporation (VIPC)
Jeeva is a best-in-class solution for gathering clinical information with best-in-class customer service—two thumbs up.
David Hirsch, Founder, Special Father's Network, 21st Century Dads Foundation
David HirschFounder, Special Father's Network, 21st Century Dads Foundation
We are proud that Jeeva emerged as #1 on the National Science Foundation (NSF) Innovation-Corps Program leaderboard.
Josh Green, PMP George Mason University ICAP
Josh Green, PMPDirector ICAP, Small Business Development Center, George Mason University
Jeeva is a leader in the clinical trials software industry, with faster patient recruitment, focusing on global patient engagement.
Christiaan Engstrom Talencio Serious Talent Chats
Christiaan EngstromVice President, Talencio, Serious Talent Chats
We need to bring healthcare and product development costs down, especially in the developing world. Clinical trial costs are a significant part of product development costs. We are confident that by partnering with Jeeva, we can find the correct value-for-money proposition without compromising quality.
Shirish Arya
Shirish Arya Director of Strategy at ImmunoACT
Previous
Next
Read all Testimonials

Ready to Explore Jeeva eClinical Cloud for Your Study?

Jeeva eClinical Cloud modules and packages are designed to be disease-agnostic, device-agnostic, flexible, and modular to support patient-preferred decentralized or hybrid trial operations. Schedule a 30-minute call today to determine the fit. We will help you identify technology or protocol complexity gaps to enable an informed decision.

Request Demo
Learn More

Jeeva Clinical Trials Inc.

10432 Balls Ford Rd Suite 300
Manassas, VA 20109
Modernize Clinical Research with Human-Centric Software and CRO Solutions
Twitter Icon - Footer Linkedin Icon - Footer Youtube Icon - Footer Facebook Icon - Footer Instagram Icon - Footer

Software & CRO Solutions

Company

Quick Links